2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Eisenmenger Complex: new trials by email Literature Review of Eisenmenger Complex trials Research Report on Eisenmenger Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome Macitentan 10 mg tablet, once daily. - Pulmonary Arterial Hypertension | Phase 3 | Terminated | Actelion | 217 | 2013-09-10 | 2019-04-16 |
| Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients Sildenafil, Placebo - Pulmonary Arterial Hypertension (PAH) | Phase 3 | Terminated | Competence Network for Congenital Heart Defects | 24 | 2007-12-01 | 2012-06-06 |
Pulmonary Arterial Hypertension (2) · Hypertension (1)
Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Heart Defects, Congenital (2) · Heart Diseases (2) · Hypertension, Pulmonary (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Vascular Diseases (1)
Sildenafil Citrate (1) · Tablets (1) · macitentan (1)
Actelion (1) · Competence Network for Congenital Heart Defects (1)
Germany (2) · Austria (1) · Bulgaria (1) · Chile (1) · China (1) · France (1) · Greece (1) · Malaysia (1) · Mexico (1) · Philippines (1) · Poland (1) · Portugal (1) · Romania (1) · Russia (1) · Serbia (1)
Ingram Schulze-Neick, MD (1) · Siegrun Mebus, MD (1)